Collection of Blood From Patients With Cancer

Part of paid clinical trials in Bethesda, Maryland.

Sponsor
National Cancer Institute (NCI)
Study ID
NCT00034216
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

This study will collect blood from patients with cancer to study the level of cells which decrease the immune response (suppressor cells) before and after chemotherapy. Patients 18 years of age and older with cancer may participate. This study does not involve treatment. Participants will have about 50 ml (3 tablespoonfuls) of blood drawn. Depending on their condition, patients may be invited to enroll in a clinical research study involving chemotherapy, radiotherapy, or surgery. Additional 40-ml blood samples may be drawn during the course of treatment.

Key Dates

Start date
Jul 16, 2002
Status verified
Apr 2026

Study Design

Enrollment
1,750 participants (estimated)

Arms

  • Arm: Healthy Volunteers
    Healthy volunteers 18 years of age and older
  • Arm: Participants
    Participants with cancer 18 years of age and older

Primary Outcome Measure

Undertake genetic analysis of both prokaryotic and eukaryotic samples for advanced mutational analysis. [ Time Frame: ongoing ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
National Institutes of Health Clinical CenterBethesdaMaryland20892
National Cancer Institute Referral Office
[email protected]
888-624-1937

Find similar trials in Bethesda, MD

By condition
Breast cancerColorectal cancerLiver cancerLung cancerProstate cancer
By specialty
OncologyBreast oncologyWomen's healthGI oncologyHepatologyLung oncologyLung diseaseProstate oncologyMen's healthUrology
By research site
National Institutes of Health Clinical Center· Bethesda, MD

Related Studies